
Benitec Biopharma BNTC
€ 9.67
1.55%
Geschäftsbericht 2025
hinzugefügt 20.03.2026
Benitec Biopharma DPO 2011-2026 | BNTC
DPO Jährlich Benitec Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -556 | 1.26 K | 469 | 233 | 1.41 K | 6.94 K | 6.94 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.94 K | -556 | 2.38 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Heron Therapeutics
HRTX
|
91.4 | $ 0.8 | 2.5 % | $ 133 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Incyte Corporation
INCY
|
200 | $ 90.82 | 0.04 % | $ 17.7 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
InMed Pharmaceuticals
INM
|
129 | $ 0.79 | -3.52 % | $ 1.93 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 2.13 | 1.91 % | $ 199 M | ||
|
CorMedix
CRMD
|
79.3 | $ 6.35 | 1.6 % | $ 457 K | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.33 | 2.12 % | $ 719 M | ||
|
Kamada Ltd.
KMDA
|
106 | $ 8.33 | 0.97 % | $ 260 M |